Probiotics, long recognized for their health benefits in humans, are increasingly gaining attention for their potential to improve animal health and boost growth. In a recent interview, Deon Neveling, CEO and Co-founder of Probipher (Pty) Ltd, shared insights with Muhammad Younis on how probiotics can enhance animal diets, the difficulties
October 4, 2024: The University of Oxford, recognised for its contributions to medical science, has secured funding up to £600,000 over the next three years from Cancer Research UK to develop OvarianVax, the first vaccine designed to prevent ovarian cancer. In this project, the Cancer Research UK-funded scientists will
September 25, 2024: Cytiva, a global leader in life sciences and bioprocessing, and Pear Bio, company specialising in single-cell analysis technologies, have joined forces to advance personalised cancer treatment through innovative single-cell technology. This collaboration aims to enhance the understanding of cancer at a granular level, enabling more precise and
September 28, 2024: INBRAIN Neuroelectronics is a brain-computer interface therapeutics (BCI-Tx) specialising in graphene-based technologies, has announced the successful completion of the world’s first human procedure of its cortical interface performed on a patient undergoing brain tumour resection involving a graphene-based Brain-Computer Interface (BCI). This innovative technology aims to
September 20, 2024: Musk's brain-computer interface company, Neuralink, has announced that its latest innovation, Blindsight, has received licensing from the U.S. Food and Drug Administration (FDA). This program is aimed at helping individuals with visual impairments regain their sight. Blindsight is one of the applications of brain-computer